Helle Knudsen

Herlev, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

High-grade B-cell lymphomas with MYC and BCL2 translocations lack tumor-associated macrophages and PD-L1 expression: A possible noninflamed subgroup.

High-grade B-cell lymphomas with MYC and BCL2 translocations lack tumor-associated macrophages and PD-L1 expression: A possible noninflamed subgroup.

Journal: Hematological oncology

Published: August 27, 2020

PD-L1 expression is low in large B-cell lymphoma with MYC or double-hit translocation.

PD-L1 expression is low in large B-cell lymphoma with MYC or double-hit translocation.

Journal: Hematological oncology

Published: May 08, 2019

Stratification by MYC expression has prognostic impact in MYC translocated B-cell lymphoma-Identifies a subgroup of patients with poor outcome.

Stratification by MYC expression has prognostic impact in MYC translocated B-cell lymphoma-Identifies a subgroup of patients with poor outcome.

Journal: European journal of haematology

Published: October 22, 2018

Real world data on young patients with high-risk diffuse large B-cell lymphoma treated with R-CHOP or R-CHOEP - MYC, BCL2 and BCL6 as prognostic biomarkers.

Real world data on young patients with high-risk diffuse large B-cell lymphoma treated with R-CHOP or R-CHOEP - MYC, BCL2 and BCL6 as prognostic biomarkers.

Journal: PloS one

Published: May 11, 2017

Lack of topoisomerase copy number changes in patients with de novo and relapsed diffuse large B-cell lymphoma.

Lack of topoisomerase copy number changes in patients with de novo and relapsed diffuse large B-cell lymphoma.

Journal: Experimental hematology

Published: April 03, 2015

WHO classification 2008 of myeloproliferative neoplasms: a workshop learning effect--the Danish experience.

WHO classification 2008 of myeloproliferative neoplasms: a workshop learning effect--the Danish experience.

Journal: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica

Published: December 04, 2014

Cell of origin predicts outcome to treatment with etoposide-containing chemotherapy in young patients with high-risk diffuse large B-cell lymphoma.

Cell of origin predicts outcome to treatment with etoposide-containing chemotherapy in young patients with high-risk diffuse large B-cell lymphoma.

Journal: Leukemia & lymphoma

Published: November 08, 2014

MYC translocation partner gene determines survival of patients with large B-cell lymphoma with MYC- or double-hit MYC/BCL2 translocations.

MYC translocation partner gene determines survival of patients with large B-cell lymphoma with MYC- or double-hit MYC/BCL2 translocations.

Journal: European journal of haematology

Published: October 08, 2013

World Health Organization-defined classification of myeloproliferative neoplasms: morphological reproducibility and clinical correlations--the Danish experience.

World Health Organization-defined classification of myeloproliferative neoplasms: morphological reproducibility and clinical correlations--the Danish experience.

Journal: American journal of hematology

Published: July 15, 2013

Double-hit BCL2/MYC translocations in a consecutive cohort of patients with large B-cell lymphoma - a single centre's experience.

Double-hit BCL2/MYC translocations in a consecutive cohort of patients with large B-cell lymphoma - a single centre's experience.

Journal: European journal of haematology

Published: March 25, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026